Post-Acute COVID-19 Respiratory Symptoms in Patients With Asthma: An Electronic Health Records-Based Study

被引:12
作者
Wang, Liqin [1 ,2 ,6 ]
Foer, Dinah [1 ,2 ,3 ]
Zhang, Yuqing [2 ,4 ]
Karlson, Elizabeth W. [2 ,5 ]
Bates, David W. [1 ,2 ]
Zhou, Li [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Brigham Massachusetts Gen Hosp, Dept Med, Div Allergy & Clin Immunol, Boston, MA USA
[4] Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA USA
[5] Brigham & Womens Hosp, Dept Med, Div Rheumatol Inflammat & Immun, Boston, MA USA
[6] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 399 Revolut Dr,Ste 1315, Somerville, MA 02145 USA
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; Coronavirus; Post-viral; Natural lan-guage processing; Electronic health records; SURVIVORS; CARE;
D O I
10.1016/j.jaip.2022.12.003
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BACKGROUND: Post-viral respiratory symptoms are common among patients with asthma. Respiratory symptoms after acute COVID-19 are widely reported in the general population, but large-scale studies identifying symptom risk for patients with asthma are lacking. OBJECTIVE: To identify and compare risk for post-acute COVID-19 respiratory symptoms in patients with and without asthma. METHODS: This retrospective, observational cohort study included COVID-19-positive patients between March 4, 2020, and January 20, 2021, with up to 180 days of health care followup in a health care system in the Northeastern United States. Respiratory symptoms recorded in clinical notes from days 28 to 180 after COVID-19 diagnosis were extracted using natural language processing. Cohorts were stratified by hospitalization status during the acute COVID-19 period. Univariable and multivariable analyses were used to compare symptoms among patients with and without asthma adjusting for demographic and clinical confounders. RESULTS: Among 31,084 eligible patients with COVID-19, 2863 (9.2%) had hospitalization during the acute COVID-19 period; 4049 (13.0%) had a history of asthma, accounting for 13.8% of hospitalized and 12.9% of nonhospitalized patients. In the post-acute COVID-19 period, patients with asthma had significantly higher risk of shortness of breath, cough, bronchospasm, and wheezing than patients without an asthma history. Incident respiratory symptoms of bronchospasm and wheezing were also higher in patients with asthma. Patients with asthma who had not been hospitalized during acute COVID-19 had additionally higher risk of cough, abnormal breath-ing, sputum changes, and a wider range of incident respira-tory symptoms. CONCLUSION: Patients with asthma may have an under -recognized burden of respiratory symptoms after COVID-19 warranting increased awareness and monitoring in this pop-ulation. (c) 2022 American Academy of Allergy, Asthma & Immunology (J Allergy Clin Immunol Pract 2023;11:825-35)
引用
收藏
页码:825 / +
页数:14
相关论文
共 50 条
[1]  
Abdallah SJ, 2021, ANN AM THORAC SOC, V18, P1912, DOI 10.1513/AnnalsATS.202012-1489RL
[2]   High-dimensional characterization of post-acute sequelae of COVID-19 [J].
Al-Aly, Ziyad ;
Xie, Yan ;
Bowe, Benjamin .
NATURE, 2021, 594 (7862) :259-+
[3]   Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge [J].
Bellan, Mattia ;
Soddu, Daniele ;
Balbo, Piero Emilio ;
Baricich, Alessio ;
Zeppegno, Patrizia ;
Avanzi, Gian Carlo ;
Baldon, Giulia ;
Bartolomei, Giuseppe ;
Battaglia, Marco ;
Battistini, Sofia ;
Binda, Valeria ;
Borg, Margherita ;
Cantaluppi, Vincenzo ;
Castello, Luigi Mario ;
Clivati, Elisa ;
Cisari, Carlo ;
Costanzo, Martina ;
Croce, Alessandro ;
Cuneo, Daria ;
De Benedittis, Carla ;
De Vecchi, Simona ;
Feggi, Alessandro ;
Gai, Martina ;
Gambaro, Eleonora ;
Gattoni, Eleonora ;
Gramaglia, Carla ;
Grisafi, Leonardo ;
Guerriero, Chiara ;
Hayden, Eyal ;
Jona, Amalia ;
Invernizzi, Marco ;
Lorenzini, Luca ;
Loreti, Lucia ;
Martelli, Maria ;
Marzullo, Paolo ;
Matino, Erica ;
Panero, Antonio ;
Parachini, Elena ;
Patrucco, Filippo ;
Patti, Giuseppe ;
Pirovano, Alice ;
Prosperini, Pierluigi ;
Quaglino, Riccardo ;
Rigamonti, Cristina ;
Sainaghi, Pier Paolo ;
Vecchi, Camilla ;
Zecca, Erika ;
Pirisi, Mario .
JAMA NETWORK OPEN, 2021, 4 (01)
[4]  
Bull-Otterson L, 2022, MMWR-MORBID MORTAL W, V71, P713, DOI 10.15585/mmwr.mm7121e1
[5]   Role of viral respiratory infections in asthma and asthma exacerbations [J].
Busse, William W. ;
Lemanske, Robert F., Jr. ;
Gern, James E. .
LANCET, 2010, 376 (9743) :826-834
[6]   Persistent Symptoms in Patients After Acute COVID-19 [J].
Carfi, Angelo ;
Bernabei, Roberto ;
Landi, Francesco .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (06) :603-605
[7]   Follow-up of adults with noncritical COVID-19 two months after symptom onset [J].
Carvalho-Schneider, Claudia ;
Laurent, Emeline ;
Lemaignen, Adrien ;
Beaufils, Emilie ;
Bourbao-Tournois, Celine ;
Laribi, Said ;
Flament, Thomas ;
Ferreira-Maldent, Nicole ;
Bruyere, Franck ;
Stefic, Karl ;
Gaudy-Graffin, Catherine ;
Grammatico-Guillon, Leslie ;
Bernard, Louis .
CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (02) :258-263
[8]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[9]   Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 [J].
Chopra, Vineet ;
Flanders, Scott A. ;
O'Malley, Megan ;
Malani, Anurag N. ;
Prescott, Hallie C. .
ANNALS OF INTERNAL MEDICINE, 2021, 174 (04) :576-578
[10]   Characterizing long COVID in an international cohort: 7 months of symptoms and their impact [J].
Davis, Hannah E. ;
Assaf, Gina S. ;
McCorkell, Lisa ;
Wei, Hannah ;
Low, Ryan J. ;
Re'em, Yochai ;
Redfield, Signe ;
Austin, Jared P. ;
Akrami, Athena .
ECLINICALMEDICINE, 2021, 38